Choksi Laboratories [CHOKSILA] vs Sai Life Sciences [SAILIFE] Detailed Stock Comparison

Choksi Laboratories Ltd.

BSE
Loading...

Sai Life Sciences Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Choksi Laboratories Ltd. wins in 8 metrics, Sai Life Sciences Ltd. wins in 10 metrics, with 0 ties. Sai Life Sciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Choksi Laboratories Ltd. Sai Life Sciences Ltd. Better
P/E Ratio (TTM) 37.71 64.75 Choksi Laboratories Ltd.
Price-to-Book Ratio 2.85 9.48 Choksi Laboratories Ltd.
Debt-to-Equity Ratio 120.16 18.40 Sai Life Sciences Ltd.
PEG Ratio 0.19 51.15 Choksi Laboratories Ltd.
EV/EBITDA 8.86 39.40 Choksi Laboratories Ltd.
Profit Margin (TTM) 4.17% 15.34% Sai Life Sciences Ltd.
Operating Margin (TTM) 7.41% 25.84% Sai Life Sciences Ltd.
EBITDA Margin (TTM) 7.41% 25.84% Sai Life Sciences Ltd.
Return on Equity 6.45% 7.99% Sai Life Sciences Ltd.
Return on Assets (TTM) 2.33% 5.38% Sai Life Sciences Ltd.
Free Cash Flow (TTM) $40.91M $-552.35M Choksi Laboratories Ltd.
1-Year Return 12.14% 53.25% Sai Life Sciences Ltd.
Price-to-Sales Ratio (TTM) 1.58 10.00 Choksi Laboratories Ltd.
Enterprise Value $988.26M $219.67B Sai Life Sciences Ltd.
EV/Revenue Ratio 2.22 10.12 Choksi Laboratories Ltd.
Gross Profit Margin (TTM) 80.48% 45.92% Choksi Laboratories Ltd.
Revenue per Share (TTM) $64 $103 Sai Life Sciences Ltd.
Earnings per Share (Diluted) $2.68 $15.83 Sai Life Sciences Ltd.
Beta (Stock Volatility) 0.06 N/A N/A

Choksi Laboratories Ltd. vs Sai Life Sciences Ltd. Stock Performance Analysis

Loading Price Chart...

CHOKSILA
SAILIFE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Choksi Laboratories Ltd.2.83%-7.99%21.15%31.75%-6.05%-3.17%
Sai Life Sciences Ltd.1.90%0.57%5.18%13.28%30.48%26.38%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Choksi Laboratories Ltd.12.14%183.17%859.21%968.12%807.14%566.67%
Sai Life Sciences Ltd.53.25%64.85%64.85%64.85%64.85%64.85%

Performance & Financial Health Analysis: Choksi Laboratories Ltd. vs Sai Life Sciences Ltd.

MetricCHOKSILASAILIFE
Market Information
Market Cap i₹703.84M₹217.06B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,105509,735
90 Day Avg. Volume i4,089545,743
Last Close₹125.45₹1,159.30
52 Week Range₹81.85 - ₹236.70₹716.60 - ₹1,184.80
% from 52W High-47.00%-2.15%
All-Time High₹236.70 (Aug 20, 2025)₹1,184.80 (May 25, 2026)
% from All-Time High-47.00%-2.15%
Growth Metrics
Quarterly Revenue Growth0.04%0.27%
Quarterly Earnings Growth1.93%0.86%
Financial Health
Profit Margin (TTM) i0.04%0.15%
Operating Margin (TTM) i0.07%0.26%
Return on Equity (TTM) i0.06%0.08%
Debt to Equity (MRQ) i120.1618.40
Cash & Liquidity
Book Value per Share (MRQ)₹35.41₹108.17
Cash per Share (MRQ)₹0.45₹14.59
Operating Cash Flow (TTM) i₹51.38M₹518.10M
Levered Free Cash Flow (TTM) i₹15.23M₹1.70B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Choksi Laboratories Ltd. vs Sai Life Sciences Ltd.

MetricCHOKSILA (Apr 26, 2026)SAILIFE (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i37.7164.75
Forward P/E iN/A51.15
PEG Ratio i0.1951.15
Price to Sales (TTM) i1.5810.00
Price to Book (MRQ) i2.859.48
Market Capitalization
Market Capitalization i₹703.84M₹217.06B
Enterprise Value i₹988.26M₹219.67B
Enterprise Value Metrics
Enterprise to Revenue i2.2210.12
Enterprise to EBITDA i8.8639.40
Risk & Other Metrics
Beta i0.06N/A
Book Value per Share (MRQ) i₹35.41₹108.17

Financial Statements Comparison: Choksi Laboratories Ltd. vs Sai Life Sciences Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCHOKSILA (2025)SAILIFE (2025)
Revenue/Sales i417.82M16.60B
Cost of Goods Sold i46.20M10.41B
COGS % of Revenue i11.1%62.7%
Gross Profit i371.62M6.19B
Gross Margin i88.9%37.3%
Research & Development iN/AN/A
Operating Income (EBIT) i50.09M2.73B
Operating Margin i12.0%16.5%
EBITDA i115.12M4.46B
EBITDA Margin i27.6%26.9%
Pre-Tax Income i21.53M2.28B
Pre-Tax Income % of Revenue i5.2%13.7%
Income Tax i6.30M575.71M
Income Tax % of Revenue i1.5%3.5%
Net Income (Profit) i15.23M1.70B
Profit Margin i3.6%10.2%

Balance Sheet & Liquidity Metrics

MetricCHOKSILA (2025)SAILIFE (2025)
Cash & Equivalents i6.12M911.19M
Total Current Assets i163.21M15.05B
Total Current Assets % of Revenue i39.1%90.6%
Total Current Liabilities i238.75M7.32B
Total Current Liabilities % of Revenue i57.1%44.1%
Long-Term Debt i159.63M1.65B
Long-Term Debt % of Revenue i38.2%9.9%
Total Shareholders Equity i236.05M21.28B
Retained Earnings i150.56M7.24B
Retained Earnings % of Revenue i36.0%43.6%
Property, Plant & Equipment i471.35M1.51B

Cash Flow Statement Comparison

MetricCHOKSILA (2025)SAILIFE (2025)
Operating Cash Flow i51.38M518.10M
Operating Cash Flow % of Revenue i12.3%3.1%
Capital Expenditures i-74.37M-3.69B
Free Cash Flow i40.91M-552.35M
FCF Margin i9.8%-3.3%
Debt Repayment i-58.75M-3.90B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCHOKSILASAILIFE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.97M211.78M
Float Shares i3.14M88.67M
% Held by Insiders i60.49%38.09%
% Held by Institutions i0.00%44.22%
% Held by Public i39.51%17.69%

Dividend Analysis & Yield Comparison: Choksi Laboratories Ltd. vs Sai Life Sciences Ltd.

MetricCHOKSILASAILIFE
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A